Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Date of authorisation: 28/06/2017, Revision: 12, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 September 2025 - 9:00

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Date of authorisation: 28/06/2017, Revision: 12, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/besponsa

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters